Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19

Overview of attention for article published in JAMA Network Open, October 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 13 news outlets
blogs: 1 blog
twitter: 50 X users
facebook: 1 Facebook page

reddit: 4 Redditors
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 163 Mendeley

So far, Altmetric has seen 14 news stories from 13 outlets.

Better COVID-19 outcomes confirmed in TNF inhibitor users

Pediatric News , 19 Aug 2025

Among patients with immune-mediated inflammatory diseases (IMIDs) who get COVID-19, the risk for hospitalization and death is…

COVID-19: Lessons learned for the path forward

Healio.com, 26 Apr 2022

April 26, 2022 3 min read Source/Disclosures Published by: Disclosures: Gelfand reports financial relationships with AbbVie…

EHR Data Support Reported Effectiveness of Ad26.COV2.S Vaccine

Cancer Therapy Advisor, 08 Nov 2021

(HealthDay News) – The effectiveness of the Johnson

EHR Data Support Reported Effectiveness of Ad26.COV2.S Vaccine

Doctors Lounge, 02 Nov 2021

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 10 additional news stories.